Literature DB >> 17916581

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

Perry Elliott1, Bert Andersson, Eloisa Arbustini, Zofia Bilinska, Franco Cecchi, Philippe Charron, Olivier Dubourg, Uwe Kühl, Bernhard Maisch, William J McKenna, Lorenzo Monserrat, Sabine Pankuweit, Claudio Rapezzi, Petar Seferovic, Luigi Tavazzi, Andre Keren.   

Abstract

In biology, classification systems are used to promote understanding and systematic discussion through the use of logical groups and hierarchies. In clinical medicine, similar principles are used to standardise the nomenclature of disease. For more than three decades, heart muscle diseases have been classified into primary or idiopathic myocardial diseases (cardiomyopathies) and secondary disorders that have similar morphological appearances, but which are caused by an identifiable pathology such as coronary artery disease or myocardial infiltration (specific heart muscle diseases). In this document, The European Society of Cardiology Working Group on Myocardial and Pericardial Diseases presents an update of the existing classification scheme. The aim is to help clinicians look beyond generic diagnostic labels in order to reach more specific diagnoses.

Entities:  

Mesh:

Year:  2007        PMID: 17916581     DOI: 10.1093/eurheartj/ehm342

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  619 in total

1.  Hypertrophic obstructive cardiomyopathy and mitral regurgitation in Libman-Sacks endocarditis.

Authors:  Go Yamashita; Naoki Kanemitsu; Yasuaki Nakashima; Takehiko Matsuo; Takeichiro Nakane; Masanori Honda; Hitoshi Okabayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-12-05

Review 2.  The role of echocardiographic deformation imaging in hypertrophic myopathies.

Authors:  Maja Cikes; George R Sutherland; Lisa J Anderson; Bart H Bijnens
Journal:  Nat Rev Cardiol       Date:  2010-05-11       Impact factor: 32.419

3.  Cardiac abnormalities in primary hyperoxaluria.

Authors:  Farouk Mookadam; Travis Smith; Panupong Jiamsripong; Sherif E Moustafa; Carla G Monico; John C Lieske; Dawn S Milliner
Journal:  Circ J       Date:  2010-09-29       Impact factor: 2.993

Review 4.  Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Mireia Alcalde; Oscar Campuzano; Georgia Sarquella-Brugada; Elena Arbelo; Catarina Allegue; Sara Partemi; Anna Iglesias; Antonio Oliva; Josep Brugada; Ramon Brugada
Journal:  Clin Res Cardiol       Date:  2014-11-15       Impact factor: 5.460

5.  Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice.

Authors:  Saskia Schlossarek; Friederike Schuermann; Birgit Geertz; Giulia Mearini; Thomas Eschenhagen; Lucie Carrier
Journal:  J Muscle Res Cell Motil       Date:  2011-11-11       Impact factor: 2.698

Review 6.  Chromosomal regulation by MeCP2: structural and enzymatic considerations.

Authors:  N J Bowen; M B Palmer; P A Wade
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

Review 7.  The MOGE(S) classification for cardiomyopathies: current status and future outlook.

Authors:  Julian G Westphal; Angelos G Rigopoulos; Constantinos Bakogiannis; Sarah E Ludwig; Sophie Mavrogeni; Boris Bigalke; Torsten Doenst; Matthias Pauschinger; Carsten Tschöpe; P Christian Schulze; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

8.  Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.

Authors:  Marco L Alves; Fernando A L Dias; Robert D Gaffin; Jillian N Simon; Eric M Montminy; Brandon J Biesiadecki; Aaron C Hinken; Chad M Warren; Megan S Utter; Robert T Davis; Sadayappan Sakthivel; Jeffrey Robbins; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  Circ Cardiovasc Genet       Date:  2014-02-28

Review 9.  Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease.

Authors:  Cristina Basso; Fiorella Calabrese; Annalisa Angelini; Elisa Carturan; Gaetano Thiene
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

10.  Myocardial 123I-MIBG scintigraphy predicts an impairment in myocardial functional reserve during dobutamine stress in patients with idiopathic dilated cardiomyopathy.

Authors:  Satoru Ohshima; Satoshi Isobe; Daisuke Hayashi; Shinji Abe; Katsuhiko Kato; Toyoaki Murohara
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-25       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.